Robert W. Fairbairn, Director at BlackRock Health Sciences Trust II (BMEZ), bought 15,000 shares at $20.00 ($300K) on 2020-01-28, disclosed to the SEC on 2020-01-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| BMEZ | SELL | 2025-12-22 | $308K | — | Filing → |
| BTX | SELL | 2025-12-22 | $286K | — | Filing → |
| ECAT | BUY | 2022-05-13 | $1.2M | — | Filing → |